468 Participants NeededMy employer runs this trial

Solriamfetol for ADHD

Recruiting at 8 trial locations
Age: < 18
Sex: Any
Trial Phase: Phase 3
Sponsor: Axsome Therapeutics, Inc.
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
1 Power Preferred Clinic1 of this trial's clinic is considered top 20 on Power

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to \<18 years with ADHD.

Are You a Good Fit for This Trial?

This trial is for adolescents aged 12 to under 18 years who have been diagnosed with ADHD. Participants should generally be in good health aside from their ADHD.

Inclusion Criteria

Has your child been told by a doctor that they have ADHD?
Is ADHD the main health problem your child has?

Exclusion Criteria

Does your child have any other health or mental health problems?
Can your child go to the study visits and do what the study asks?

What Are the Treatments Tested in This Trial?

Interventions

  • Solriamfetol

Trial Overview

The study is testing two different doses of the drug solriamfetol compared to a placebo (inactive pill) over six weeks. Participants are randomly assigned to one of the groups, and neither they nor the researchers know which treatment they're getting.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Placebo Group

Group I: Solriamfetol Dose BExperimental Treatment1 Intervention
Group II: Solriamfetol Dose AExperimental Treatment1 Intervention
Group III: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Axsome Therapeutics, Inc.

Lead Sponsor

Trials
34
Recruited
11,600+